(Updated - August 8, 2023 4:48 PM EDT)

Stifel analyst Alex Thompson downgraded Morphic Therapeutic (NASDAQ: MORF) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE